Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure from COVID-19: A Randomized Placebo Controlled Dosing Clinical Trial
Chest 2023 Jun 23;[EPub Ahead of Print], AL Lightner, V Sengupta, S Qian, JT Ransom, S Suzuki, DJ Park, TI Melson, BP Williams, JJ Walsh, M AwiliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.